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Abstract
Background: HIV testing among tuberculosis patients is critical in improving morbidity and mortality as those
found to be HIV positive will be offered a continuum of care including ART if indicated. We conducted a cross-
sectional study in three Kampala City primary care clinics: to assess the level of HIV test uptake among newly
diagnosed pulmonary tuberculosis (PTB) patients; to assess patient and health worker factors associated with HIV
test uptake; and to determine factors associated with HIV test uptake at the primary care clinics.
Methods: Adult patients who had been diagnosed with smear-positive PTB at a primary care clinic or at the
referral hospital and who were being treated at any of the three clinics were interviewed. Associations between
having taken the test as the main outcome and explanatory variables were assessed by multivariate logistic
regression.
Results: Between April and October 2007, 112 adults were included in the study. An HIV test had been offered to
74 (66%). Of the 112 patients, 61 (82%) had accepted the test; 45 (74%) had eventually been tested; and 32 (29%)
had received their test results.
Patients who were <25 yeas old, female or unemployed, or had reported no previous HIV testing, were more likely
to have been tested. The strongest predictor of having been tested was if patients had been diagnosed at the
referral hospital compared to the city clinic (adjusted OR 24.2; 95% CI 6.7-87.7; p < 0.001). This primarily reflected
an “opt-out” (uptake 94%) versus an “opt-in” (uptake 53%) testing policy.
Conclusions: The overall HIV test uptake was surprisingly low at 40%. The HIV test uptake was significantly higher
among TB patients who were identified at hospital, among females and in the unemployed.
Background
Testing all patients routinely for HIV in settings with
generalized HIV epidemics has the benefit of diagnosing
the infection early and thereby preventing morbidity,
mortality and sustained transmission through initiating
prophylaxis and timely antiretroviral treatment (ART)
[1-4]. Test uptake varies considerably from 12% to 98%
across different settings and patients categories, but par-
ticularly with the testing approach used [5-8]. HIV test
uptake levels of 12-62% have been reported when the
test is offered using an “opt-in” approach [7,8], i.e. when
patients are not tested unless they specifically request
to. Uptake tends to be much higher (70-98%) when the
HIV test is offered using an “opt-out” (or “provider-
initiated”) approach by which the HIV test is considered
an integral part of the diagnostic procedures and
patients are tested unless they specifically indicate that
they do not want to [5,6].
HIV testing is particularly important in tuberculosis
(TB) because mortality among HIV-infected TB patients
is substantially increased unless co-trimoxazole preven-
tive treatment or ART are provided [4,9-11]. TB was
responsible for 1.3 million deaths among HIV negative
incident cases in 2007 [12] and was the most common
cause of mortality among HIV patients in sub-Saharan
Africa [13,14], where HIV prevalence among tuberculo-
sis patients ranged from 20 to 60% between 1995 and
2005 [15-18]. There is consensus that all TB patients
should be tested for HIV infection in order to offer
ART if positive and indicated [19]. So far few data have
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been published about HIV testing practices among TB
patients in sub-Saharan Africa. Although some studies
have shown high uptake levels [20,21], the WHO esti-
mated only 0.5 million TB patients (37% of all notified
cases) knew their HIV status in Africa in 2007 [12]. The
reasons for these differences are largely unknown. HIV
testing at the time of TB diagnosis is an excellent
opportunity to make a new HIV diagnosis and get
patients in care.
HIV testing in Uganda has evolved over the years. In
the late 1990s and early 2000s only a small proportion
of patients had access to HIV testing, mainly due to
absence of the service and the policy of testing in place.
Until recently, HIV testing in Uganda was based on a
voluntary request from the patient to be tested (“opt-in”
approach) at static testing centres and later on during
outreach services [7,22]. In 2005 a new policy was
adopted in Uganda that advocated for a shift to “opt-
out” testing in order to scale up access to HIV testing
and the blood samples are tested for HIV using a serial
algorithm recommended by the Ministry of Health [23].
We studied HIV test uptake among TB patients in
Uganda, one of the 22 countries with a high TB burden:
Uganda notified 42,000 smear positive cases to the
WHO in 2007 [12]. About 50% of TB patients, in
Uganda, are estimated to be co-infected with HIV [24].
The main objectives of the study were to assess the
level of HIV test uptake among newly diagnosed TB
patients treated at the primary health care facilities in
Kampala city, and the factors associated with this
uptake. The secondary objective was to determine the
factors associated with HIV test uptake at the primary
care clinics.
Methods
Study setting
Kampala, the capital city of Uganda, has an estimated
resident population of 1.4 million people [25]. The day
population attracted by services and various economic
activities nearly doubles the resident population. The
city is divided into five administrative divisions [26].
Kiruddu, Kisenyi and Kiswa are three of the ten pri-
mary health centres operated by the Kampala City
Council (KCC), offering mainly outpatient services
including sputum smear microscopy and TB treatment
in accordance with the DOTS strategy. These centres
were purposefully chosen considering geographical
representation. Kiruddu health centre is located in a
semi-rural residential area. Kisenyi health centre is
located in the middle of a densely populated low-income
area. Kiswa health centre is located in an industrial area
of the city. Each study site is located in a separate divi-
sion of the city. These centres are level III health centres
and are primary health care outlets. The health centres
are faced with the challenges of heavy patient load,
understaffing and periodic stock-outs of different com-
modities. Health services at these health centres are free
of charge [27].
Complicated cases are usually referred to hospital.
Some patients are diagnosed and initiated on TB treat-
ment in hospitals, notably the main referral hospital,
Mulago, and are referred to one of the KCC clinics to
complete treatment. These patients are then registered
for continuation of treatment at the KCC clinics. After
registration at the clinic, follow-up and review of the
patients is performed by KCC staff.
Kampala city alone, reports about one quarter of the
over 40,000 TB cases notified annually in Uganda [28].
Between 39% and 50% of these cases are estimated to be
co-infected with HIV [20,24]. The number of TB
patients (all forms of TB) registered for treatment at the
three KCC clinics was 580 in 2007, 68% (395/580) of
which had smear-positive pulmonary TB.
Study design
Between 1st April and 17th October 2007, we conducted
a cross-sectional study about HIV testing practices
among patients with pulmonary tuberculosis in three
KCC clinics. All consenting patients aged ≥ 15 years
with sputum smear-positive pulmonary TB, residing
within Kampala city or 16 km from the city centre who
were treated at the three clinics were interviewed using
a structured questionnaire between 2 and 8 weeks fol-
lowing treatment initiation. Data were collected by
trained interviewers using pretested questionnaires. The
interviews were conducted during patients’ treatment
visits. The very sick patients; patients unable to consent
due to mental illness; and those patients aged ≥ 15 to
18 years without a parent or guardian’s consent were
excluded from the study. Consecutive recruitment was
done at each of the three study sites until a total pooled
sample was realised.
Data were collected on whether an HIV test had been:
offered, accepted, done and test results received. Data
were also collected on various factors that might have
affected uptake of an HIV test including age and sex;
educational, marital and employment status; household
wealth; type of health facility where the patient was first
diagnosed and initiated on TB treatment; the type and
attitude of the health worker offering the test; and
patient knowledge about benefit of doing an HIV test
and knowledge about preventing HIV infection. Smear
positive TB was defined according to international
guidelines [29].
A recent study had found a high HIV test uptake level
of 98% among patients attending two large tertiary
urban hospitals [5]. In another study among registered
TB patients the HIV test uptake was 87% [21]. We
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reasoned that the HIV test uptake among TB patients
attending urban health centres would be somewhere in
the middle, at 92.5%. We put the level at 90%. A sample
size of 96 patients was calculated to be sufficient to
detect a test uptake of 90% with an error margin of 6%
at the 95% confidence interval [5,21].
Data handling and statistical analysis
Data were collected, entered into a custom programmed
database using ASP.NET and stored in Microsoft SQL
Server Express Edition database (Microsoft Software,
Seattle, WA, USA). Statistical analyses were carried out
using Stata statistical software, version 10 (Stata Corp,
College Station, TX, USA).
The wealth of a patient’s household was determined
based on asset scores derived from the Uganda Demo-
graphic and Health Survey performed in 2000 [30]. A
composite value of the household wealth was calculated
as the total sum of the scores assigned to each asset
owned or absent and divided into tertiles. Responses to
question items about knowledge were each given a score
leading to a dichotomous variable.
Excluded from the analyses were patients who were
known to be HIV infected before the TB diagnosis. In
the primary analysis, participants who had been tested
were compared to those who had not. The secondary
analysis compared the patients who had accepted an
HIV test when offered to those who had not. Accep-
tance of the HIV test was calculated as the number of
patients who accepted the test divided by the total num-
ber of participants offered the test. Overall uptake of
routine HIV testing was calculated as the proportion of
those who were actually tested relative to those who
were eligible for the test. Associations between out-
comes and explanatory variables were assessed by odds
ratios in univariable analyses. Variables were entered in
a multivariate logistic regression model if they showed a
univariable association at p < 0.25, and included in the
final model if they showed a significant association (at
p < 0.05), or if they confounded the association with
other variables in the model. Age and sex were included
irrespective of their strength of association. All tests
were done at the 5% significance level. In the secondary
analysis, variables were examined for their association
with having been offered an HIV test and with having
accepted the test if diagnosed at the primary care KCC
clinics.
Ethical review
This study was reviewed and approved by the Makerere
University School of Public Health (MUSPH), the
Uganda National Council of Science and Technology
(UNCST) and the Medical Ethics Committee of the
Academic Medical Centre, Amsterdam. Informed
consent was obtained from all participants. The consent
forms were translated into Luganda, the commonly used
local language. Patients between 15 and 18 years for
whom it was not practically possible to get additional
consent of the parents or guardians were excluded from
the study.
Results
A total of 120 patients on treatment consented to the
interview. Eight were known to be HIV infected at the
time of TB diagnosis, leaving 112 patients for the analy-
sis (93%). Fifteen (13%) participants were recruited from
Kiruddu, 61 (54%) from Kisenyi and 36 (32%) from
Kiswa health centre. There were no significant differ-
ences between patients recruited from the various clinics
in terms of sex (p = 0.56) and age (p = 0.54). Thirty-
eight (34%) had been diagnosed with TB at the national
referral hospital and then referred to the KCC clinics;
the remaining 66% were both diagnosed with and
started on TB treatment at the three clinics. The median
age of the study patients was 30 years (range, 17-83).
The majority was ≤ 30 years of age and 55% were male
(Table 1).
Of 112 study participants, 74 (66%) had been offered
an HIV test (Figure 1). Out of the 112 participants
included in the study, 61 (55%) accepted to be tested.
Overall 40% (45/112) of participants had been tested for
HIV infection during or following the diagnostic process
leading to their current treatment for TB. Thirty two
(29%) received their test results.
When we stated our null hypothesis as “H0 = P is
equal 90%” and the two-sided alternative hypothesis test
as “H1 = P is not equal 90%”, we estimated the HIV test
uptake to be 40.2%; 95% CI 31.1%-49.3%. The test static,
z, was equal to 10.8 and p was less than 0.001. We had
sufficient evidence to reject the null hypothesis.
In the univariable analysis: the type of health facility
where TB was diagnosed, a history of previous HIV test-
ing and employment status were associated with having
been tested (Table 2). Household wealth was not asso-
ciated with being tested for HIV infection: middle tertile
(OR 0.79 95% CI 0.31-2.04), upper tertile (OR 1.19 95%
CI 0.47-2.97); data not shown. High education level was
also not associated with being tested for HIV infection
(OR 1.02 95% CI 0.47-2.17).
The likelihood of having been tested was not signifi-
cantly associated with knowledge of two or more bene-
fits of doing an HIV test (OR 1.44 95% CI 0.62-3.32),
with knowledge of at least two ways in which HIV is
transmitted (OR 0.73 95% CI 0.34-1.57), or with a per-
ceived kind attitude of the health care worker (OR 1.55
95% CI 0.47-5.11).
In the multivariable analysis, the most important pre-
dictor of having been tested for HIV was whether
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patients had been diagnosed with TB at the referral hos-
pital or at one of the KCC clinics (adjusted odds ratio
(aOR) 24.22 95% CI 6.69-87.73, table 2). In addition,
patients in some form of employment were less likely to
have been tested compared to those with no employment
(aOR 0.20 95% CI 0.05-0.76), as were patients with a his-
tory of previous HIV testing (OR 0.15 95% CI 0.05-0.48).
Figure 2 shows test offer and testing uptake of
patients according to the health facility where TB was
diagnosed. Ninety percent (34/38) of patients diagnosed
at the referral hospital had been offered an HIV test
compared to 54% (40/74) of patients diagnosed at the
KCC primary care clinics (p < 0.001). Acceptance of the
HIV test was 82% (31/38) in the referral hospital and
41% (30/74) in the KCC clinics (p < 0.069). Of the 38
patients from the referral hospital who accepted to be
tested, 76% (29/38) were eventually tested in the referral
hospital compared to 16 out of 74 patients at the pri-
mary care KCC clinics (22%, p < 0.001).
Although more patients diagnosed at the referral hos-
pital got their test results, 58% (22/38) compared to
those diagnosed at the KCC clinics, 14% (10/74), this
difference was not statistically significant (p < 0.343).
In the secondary analysis, variables were examined for
their association with having been offered an HIV test
and with having accepted the test if diagnosed at the
primary care KCC clinics. Table 3 shows associations
with having been tested once offered the test with pre-
dictor variables. Age, sex, employment status and history
of previous HIV testing were not associated with HIV
test uptake in the multivariable analysis.
Discussion
In this study 40% of the tuberculosis patients who were
treated at city clinics had been tested for HIV. Out of
the 61 patients who accepted to be tested, 74% (45/61)
were actually tested for HIV infection. This uptake level
is low compared to recent studies that were carried out
in Ugandan referral hospitals [5,6]. In line with this, we
found a significantly higher HIV test uptake among
patients who had been diagnosed with TB and started
on treatment in the referral hospital and were subse-
quently referred to a city clinic than among patients
who had been diagnosed with TB at the city clinic
initially.
One possible cause for this difference is that patients
received and admitted in the tertiary referral hospitals
were more likely to have severe or long-standing illness,
which may have prompted HIV testing as part of man-
agement of chronic illnesses. Perhaps more importantly,
a policy of “opt-out” testing was already well established
in the referral hospital at the time of this study.
Although the “opt-out” testing policy had officially been
introduced at national level, this had apparently not yet
been fully implemented at the city council clinics. Not
only had not all patients been offered an HIV test, only
75% had accepted it, which likely reflects an actual “opt-
in” approach in these clinics.
These results indicate that in practice “opt-out” HIV
testing was implemented at the referral hospital, but not
yet at the KCC clinics. Moreover, 47% of patients diag-
nosed with TB in the city clinics had no HIV test done
even though testing had been accepted. This suggests that
problems in service provision played an additional role.
The low uptake at the city clinics is in line with a
study conducted recently in rural Tanzania just before
the roll-out of ART [8]. The uptake of 40% in our study
was higher than the 12% in the Tanzanian study. The
timings of these two studies were somewhat similar
since in both settings provision of ART services was just
beginning. This observation lends support to the view
that, when the provision of ART services are absent or
just beginning, the uptake of HIV testing is usually low.
Table 1 Socio-demographic characteristics of 112 smear-
positive pulmonary tuberculosis patients included in a
study on HIV test uptake, Kampala, 2007
Socio-demographic variable N (%)
Age
15 - 24 years 30 (26.8%)
25 - 34 years 46 (41.1%)
35 - 44 years 21 (18.8%)
45 - 54 years 10 (8.9%)
≥ 55 years 5 (4.5%)
Sex
Male 61 (54.5%)
Female 51 (45.5%)
Education level
None 7 (6.3%)
Primary (P1-P4) 15 (13.4%)
Primary (P5-P7) 38 (33.9%)
Secondary (S1-S4) 32 (28.6%)
Secondary (S5-S6) 10 (8.9%)
University 10 (8.9%)
Marital status
Single 38 (33.9%)
Married 46 (41.1%)
Divorced/separated 21 (18.8%)
Widowed 6 (5.4%)
Co-habiting 1 (0.9%)
Employment status
Unemployed 35 (31.2%)
Employed* 77 (68.8%)
*some form of employment including formal, informal and self-employed
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The sex of patient, history of previous HIV testing and
employment status, were other factors associated with
doing an HIV test. Similar studies have shown similar
associations with HIV test uptake [4,15]. A study carried
out in an urban hospital found a high HIV test uptake
among patients before admission [6]. Our study did not
find a significant association between taking an HIV test
and formal education nor income.
Unemployment was a factor found to be significantly
associated with HIV test uptake in a study carried out
in a public district hospital in south Ethiopia [31]. Our
study findings are similar to these findings in this study
possibly because both settings are from developing
countries and both offering Directly Observed Therapy,
Short Course (DOTS).
The study carried out in Tanzania found prior knowl-
edge of VCT among others as important predictors of
VCT completion [8]. Our study did not find an associa-
tion between knowledge of benefits of taking an HIV
test, transmission of HIV infection or cause of HIV
infection and taking the HIV test.
Among the patients who were tested, 58% and 14%
got their results from the referral hospital and the KCC
primary care clinics respectively. The difference in get-
ting test results was not statistically significant. The low
level of getting test results in our study findings
Figure 1 Flow chart showing the participants included in the analysis. Percentages refer to proportion out of 112.
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contrasts the results of a recent study that found that
nearly all patients (95%) who had been offered HIV
counselling and testing prior to admission had received
their test results [6]. Our study findings show that a
sizeable proportion of patients may not be entering into
care because they don’t know their HIV status. Improve-
ment in the burden of TB or HIV may not be achieved
if patients are not getting into care.
The true level of HIV test uptake among TB patients
can as low as 31.1% and as high as 49.3%. Our study
findings are similar to those of a recent study carried
out in the referral hospital that found the test uptake to
be low at 39% [20]. The implication here is that either
the HIV test is not being offered to TB patients or the
TB patients are not accepting to be tested after being
offered the HIV test. There may be other operational
factors yet to be determined that are responsible for TB
patients not being tested.
Our study did not find any factor statistically signifi-
cantly associated with HIV test uptake in the city clinics.
However, patients with positive history of previous HIV
testing were less likely to be tested again for HIV during
their current treatment for TB, although this was not
significant. This result may be due to the fact that the
numbers were too small to give meaningful multivari-
able analysis.
Our study had some limitations. It was not designed
to compare the two approaches of “opt-out” and
“opt-in” HIV testing: we merely observed practices and
found out that the patients started on TB treatment at
the referral hospital had in fact been subjected to an
“opt-out” system, whereas the city clinics appeared still
Table 2 Associations of testing uptake with baseline characteristics of 112 smear-positive pulmonary tuberculosis
patients included in a study on HIV test uptake, Kampala, 2007
Had HIV test Univariable analysis Multivariable analysis
Yes No
Variable N (%) N (%) Unadjusted
Odds Ratio
95% CI Adjusted
Odds ratio
95% CI p-value
Age
≤ 25 years 18 (48.7) 19 (51.3) 1 - 1 -
26-33 years 12 (33.3) 24 (66.7) 0.53 0.20-1.36 0.10 0.02-0.45
> 33 years 15 (38.5) 24 (61.5) 0.66 0.27-1.64 0.48 0.14-1.65 0.004
Sex
Male 24 (39.3) 37 (60.7) 1 - 1 -
Female 21 (41.2) 30 (58.8) 1.08 0.50-2.30 3.42 1.02-11.40 0.037
Education level
Low 24 (40.0) 36 (60.0) 1
High 21 (40.4) 31 (59.6) 1.02 0.47-2.17 - - -
Employment status
Unemployed 9 (25.7) 26 (74.3) 1 - 1 -
Employed 36 (46.8) 41 (53.2) 0.39 0.16-0.95 0.20 0.05-0.76 0.012
Household wealth
Lower tertile 15 (40.5) 22 (59.5) 1
Middle tetile 13 (35.1) 24 (64.9) 0.79 0.31-2.04 - - -
Higher tertile 17 (44.7) 21 (55.3) 1.19 0.47-2.97 - - -
Health Facility at which TB was diagnosed
KCC clinic 16 (21.6) 58 (78.4) 1 - 1 -
Hospital 29 (76.3) 9 (23.7) 11.68 4.61-29.62 24.22 6.69-87.73 <0.001
Previous HIV testing
No 28 (56.0) 22 (44.0) 1 - 1 -
Yes 17 (27.9) 44 (72.1) 0.30 0.14-0.67 0.15 0.05-0.48 <0.001
Adjusted odds ratios: adjusted for all other variables in the model. 95% CI: 95% confidence interval.
Sendagire et al. BMC Public Health 2010, 10:177
http://www.biomedcentral.com/1471-2458/10/177
Page 6 of 9
to be following the “opt-in” approach. Other site differ-
ences e.g. availability of specialized care and co-localiza-
tion of HIV services might indeed account for the
improved offer and uptake of HIV testing at the referral
hospital.
Study outcomes were obtained retrospectively and
relied entirely on patient self-report. Patients seen at the
referral hospital could have been sicker, had a longer
day at the hospital or HIV testing policy was implemen-
ted better which may all result in better recall about
HIV testing offer and uptake. Although the total pooled
sample was representative of the city population as prac-
tically as was possible, the fact that study sites were
purposefully chosen and not randomly selected could
have introduced some form of selection bias in our find-
ings. The sampling strategy may have resulted in a pos-
sible selection bias because random sampling of the
sites was not done.
The sample size of 112 patients had high power to
detect our primary outcome of the HIV test uptake
among patients receiving care in urban health centres
and the factors associated with this uptake. The sample
size was however, not powered enough to pick the sec-
ondary outcome of the factors associated with the HIV
test uptake among the patients diagnosed and registered
for treatment at the KCC clinics when taken alone.
Figure 2 Breakdown of patients according to health facility where tuberculosis was diagnosed. Percentages refer to proportion out of 74
and 38 respectively.
Sendagire et al. BMC Public Health 2010, 10:177
http://www.biomedcentral.com/1471-2458/10/177
Page 7 of 9
Nonetheless this study illustrates the complexity of not
only offering HIV testing in TB clinics, but also the
challenge of ensuring that all steps from acceptance to
testing to receipt of the results in a primary health care
setting are followed. The study further demonstrates
that operational research in HIV testing at the primary
care level as recommended by the WHO is feasible in
resource limited settings.
Conclusions
The overall HIV test uptake was surprisingly low at 40%.
The HIV test uptake was significantly higher among TB
patients who were identified at hospital, among females
and in the unemployed. We recommend that further
studies be done in which the two approaches are com-
pared in similar settings. We also recommend further
operational studies into the barriers to implementation
of HIV testing in the primary health care facilities.
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